News
Pharmaceutical Technology on MSN4d
FDA approves Abeona’s $3.1m cell therapy for rare skin diseaseAbeona has won FDA approval for Zevaskyn, setting up a commercial challenge to Krystal Biotech in the rare skin disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback